Abuse-resistant opioid dosage form

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/485 (2006.01) A61K 31/00 (2006.01) A61K 31/137 (2006.01) A61K 31/444 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2486095

The present invention pertains to a pharmaceutical dosage form comprising an opioid analgesic and a nontoxic N-methyl-D-aspartate receptor antagonist wherein the pharmaceutical dosage form is substantially free of an opioid antagonist. The nontoxic N-methyl-D-aspartate receptor antagonist is present in an opioid euphoria-inhibiting amount to prevent or discourage abuse.

L'invention concerne une forme posologique pharmaceutique comprenant un analgésique opioïde et un antagoniste du récepteur N-méthyl-D-aspartate non toxique, qui est sensiblement dépourvue d'un antagoniste opioïde. Ledit antagoniste du récepteur N-méthyl-D-aspartate non toxique est présent à une dose empêchant un sentiment d'euphorie provoqué par un opioïde afin de prévenir ou de décourager une utilisation abusive.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Abuse-resistant opioid dosage form does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Abuse-resistant opioid dosage form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Abuse-resistant opioid dosage form will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1555501

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.